Cholestasis of sepsis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 17, Issue 3, 2003, Pages 357-367

  Gilroy, Richard K ^a   Mailliard, Mark E ^a   Gollan, John L ^a  

^a 982000 Nebraska Medical Center ^*  (United States)

Author keywords

Cholestasis; Cytokines; Endotoxin; Hepatocyte transporters; Lipopolysaccharides; Sepsis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; METRONIDAZOLE; POLYMYXIN B; PROTEIN P55; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; BILE SALT; BILIRUBIN; CARRIER PROTEIN; CHOLESTEROL; ENDOTOXIN; GLUTATHIONE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; ORGANIC ANION TRANSPORTER; ORGANIC CATION TRANSPORTER; PHOSPHATIDYLCHOLINE; PROTEIN SODIUM DEPENDENT TRANSPORTER SODIUM TAUROCHOLIC ACID COTRANSPORTING PROTEIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ECHOGRAPHY; ENDOTOXEMIA; HISTOLOGY; HUMAN; INFLAMMATION; LABORATORY TEST; PATHOPHYSIOLOGY; SEPSIS; ABDOMINAL ABSCESS; ACALCULOUS CHOLECYSTITIS; ANEMIA; BACTERIAL TRANSLOCATION; BILE DUCT OBSTRUCTION; BILE SECRETION; BLOOD TRANSFUSION; CANCER; CELL TRANSPORT; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ELECTROLYTE BALANCE; GILBERT DISEASE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEMOLYSIS; HEPATOBILIARY SYSTEM; HEPATOMEGALY; HYPERBILIRUBINEMIA; JAUNDICE; KIDNEY DISEASE; LIVER BIOPSY; LIVER CELL MEMBRANE; LIVER DISEASE; LIVER SINUSOID; LIVER TOXICITY; MEMBRANE TRANSPORT; MICROANGIOPATHY; NONHUMAN; PAIN; PARENTERAL NUTRITION; PREMATURITY; PRURITUS; RECURRENT DISEASE; REPERFUSION INJURY; REVIEW; RISK FACTOR; CLINICAL PRACTICE; CRITICAL ILLNESS; INTRAHEPATIC CHOLESTASIS;

CHOLESTASIS, INTRAHEPATIC; CRITICAL ILLNESS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; SEPSIS;

EID: 0141688070     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6918(03)00027-1     Document Type: Article

References (60)

1. Garvin I.P. Remarks on pneumonia biliosa Southern Medical and Surgical Journal 1 1837-536
2. Trauner M. Fickert P. Stauber R.E. Inflammation-induced cholestasis Journal of Gastroenterology and Hepatology 14 1999 946-959
3. Tugwell P. Williams A.O. Jaundice associated with lobar pneumonia. A clinical, laboratory and histological study Quarterly Journal of Medicine 46 1977 97-118
4. Quale J.M. Mandel L.J. Bergasa N.V. Straus E.W. Clinical significance and pathogenesis of hyperbilirubinaemia associated with Staphylococcus aureus septicemia American Journal of Medicine 85 1988 615-618
5. Hamilton J.R. Sass-Kortsak A. Jaundice associated with severe bacterial infection in young infants Journal of Pediatrics 63 1963 121-132
6. Moseley R.H. Sepsis and cholestasis Clinics in Liver Disease 3 1999 465-475
7. Neale G. Caugley D.E. Mollin D.L. Booth C.C. Effects of intrahepatic and extrahepatic infection on liver function British Medical Journal 5485 1966 382-387
8. Boyer J.L. Molecular pathophysiology of membrane transport function in cholestasis In Arias I.M. Boyer J.L. Chisari F.V. Fausto N. et al. (eds) The Liver: Biology and Pathophysiology 2001 663-667 Lippincott Williams and Williams Philadelphia
9. Kullak-Ublick G.A. Meier P.J. Mechanisms of Cholestasis Clinics in Liver Disease 4 2000 357-385
10. Franson T.R. Hierholzer W.J. La Brecque D.R. Frequency and characteristics of hyperbilirubinaemia associated with bacteremia Reviews of Infectious Diseases 7 1985 1-9
11. Nolan J.P. Intestinal endotoxins as mediators of hepatic injury-an idea whose time has come Hepatology 10 1989 887
12. Sikuler E. Guetta V. Keynan A. et al. Abnormalities in bilirubin and liver enzyme levels in adult patients with bacteremia Archives of Internal Medicine 149 1989 2246-2248
13. Crawford J.M. Boyer J.L. Clinicopathology conferences: inflammation-induced cholestasis Hepatology 28 1998 253-260
14. Miller D.L. Keeton G.R. Webber B.L. et al. Jaundice in severe bacterial infection Gastroenterology 71 1976 94-96
15. Caruana J.A. Montes M. Camara D.S. et al. Functional and histopathologic changes in the liver during sepsis Surgery, Gynaecology and Obstetrics 154 1982 653-656
16. Gursel S. Kandemir B. Karacadag S. Telatar H. Liver in septic shock American Journal of Gastroenterology 59 1973 250-254
17. Paton A. Sepsis and cholestasis British Medical Journal 289 1984 857
18. Lechner A.J. Velasquez A. Knudsen K.R. et al. Cholestatic liver injury increases circulating TNF-α and IL-6 and mortality after Escherichia coli endotoxemia American Journal of Respiratory Critical Care Medicine 157 1998 1550-1558
19. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and cholangitis lenta. Human Pathology 1982;13:19-24.
20. Schottmuller T. Uber Cholangitis Munchener Medizinische Wochenschrift 51 1921 167-1667
21. Gimson A.E.S. Jaundice In Webb A.R. Shapiro M.J. Singer M. (eds) Oxford Textbook of Critical Care 1999 356-361 Oxford University Press Oxford
22. Hewett J.A. Roth R.A. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides Pharmacology Reviews 45 1993 381-411
23. Lee T. Boyer J.L. Molecular alterations in hepatocyte transport: mechanisms in acquired cholestatic liver disorders Seminars in Liver Disease 20 2000 373-384
24. Strazzabosco M. Spirili C. Okolicsanyi I. Pathophysiology of intrahepatic biliary epithelium Journal of Gastroenterology and Hepatology 15 2000 244-253
25. Sandhu I.S. Jarvis C. Everson G.T. Total parenteral nutrition and cholestasis Clinics in Liver Disease 3 1999 489-508
26. Maher J.J. Treatment of alcoholic hepatitis Journal of Gastroenterology and Hepatology 17 2002 448-455
27. Bohan A. Boyer T.L. Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions Seminars in Liver Disease 22 2002 123-136
28. Trauner M. Meier P.J. Boyer J.L. Molecular regulation of hepatocellular transport systems in cholestasis Journal of Hepatology 31 1999 165-178
29. Jansen P.L.M. From classic bile physiology to cloned transporters Seminars in Liver Disease 3 2002 245-250
30. Su G.L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation American Journal of Physiology 283 2002 G256-G265
31. Diehl A.M. Cytokine regulation of liver injury and repair Immunological Reviews 174 2000 160-171
32. Henderson B. Wilson M. Cytokine production by bacteria: beyond lipopolysaccharide Cytokine 8 1996 269-282
33. Thompson R. Jansen P.L.M. Genetic defects in hepatocanalicular transport Seminars in Liver Disease 3 2002 365-372
34. Haussinger D. Schmitt M. Weiergraber O. et al. Short-term regulation of canalicular transport Seminars in Liver Disease 3 2002 307-321
35. Inone Y. Bode B.P. Abcouwer S. et al. Attenuation of the endotoxin-stimulated increase in hepatic amino acid transport with a glucocorticoid receptor antagonist Surgical Research 58 1995 693-701
36. Pacitti A.J. Inone Y. Souba W.W. Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver Journal of Clinical Investigation 91 1993 474-483
37. Green R.M. Beier D. Gollan J.L. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents Gastroenterology 111 1996 193-198
38. Moseley R.H. Wang W. Takeda H. et al. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis American Journal of Physiology (Gastrointestinal and Liver Physiology) 271 1996 G137-G146
39. Bolder U. Ton-Nu H.T. Schteingart C.D. et al. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion Gastroenterology 112 1997 214-225
40. Whiting J.F. Green R.M. Rosenbluth A.B. Gollan J.L. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis Hepatology 22 1995 1273-1278
41. Trauner M. Arrese M. Lee H. et al. Endotoxin down-regulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors Journal of Clinical Investigation 101 1998 2092-2100
42. Lee J.M. Trauner M. Soroka C.J. et al. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat Gastroenterology 118 2000 163-172
43. Vos T.A. Hooiveld G.J. Koning H. et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver Hepatology 28 1998 1637-1644
44. Schmitt M. Kubitz R. Lizun S. et al. Regulation of the dynamic localization of the rat Bsep gene-encoded bile salt export pump by anisoosmolarity Hepatology 33 2001 509-518
45. Trauner M. Arrese M. Soroka C.J. et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis Gastroenterology 113 1997 255-264
46. Kubitz R. Wettstein M. Warskulat U. et al. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone Gastroenterology 116 1999 401-410
47. Denson L.A. Auld K.L. Schiek D.S. et al. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation Journal of Biological Chemistry 275 2000 8835-8843
48. - excretion and blocks the choleretic effect of nitric oxide in rat liver Hepatology 25 1997 1184-1191
49. Molina E.G. Reddy K.R. Postoperative jaundice Clinics in Liver Disease 3 1999 477-487
50. Sherlock S. Dooley J. Diseases of the Liver and Biliary System 11th edn 2002 Blackwell Oxford
51. Mandell G.L. Bennett J.E. Dolin R. Principles and Practices of Infectious Diseases 5th edn 2000 Churchill Livingstone London pp 223-236
52. Sandhu I.S. Jarvis C. Everson G.T. Total parenteral nutrition and cholestasis Clinics in Liver Disease 3 1999 489-505
53. Sigalet D.L. Short bowel syndrome in infants and children: an overview Seminars in Pediatric Surgery 10 2001 49-55
54. Capron J.P. Gineston J.L. Herve M.A. et al. Metronidazole in the prevention of cholestasis associated with total parenteral nutrition Lancet i 1983 446
55. Pappo I. Becovier H. Berry E.M. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide Journal of Parenteral and Enteral Nutrition 16 1992 529-532
56. Reinhart K. Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trial and lessons learned Critical Care Medicine 29 2001 S121-S125
57. Pittet D. Harbarth S. Suter P. et al. Impact of immunomodulating therapy on morbidity in patients with severe sepsis American Journal of Respiratory and Critical Care Medicine 160 1999 852-857
58. Gilroy R. Sudan D. Liver and small bowel transplantation: therapeutic alternatives for the treatment of liver disease and intestinal failure Seminars in Liver Disease 20 2000 437-450
59. Lazaridis K.N. Gores G.J. Lindor K.D. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders' Journal of Hepatology 35 2001 134-146
60. Spagnuolo M.I. Iorio R. Vegnente A. Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study Gastroenterology 111 1996 716-719